NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

UK approval is pretty much a given. However, the markets will not value them fairly given the history of this management and lack of meaningful follow up catalysts and the need for dilution. I think the shorts will double down on whatever UK approval spike we get. It will be easy money for them to run it back down again with this management at the helm. Plus the tired longs will add fuel to the fire by selling a large portion of their shares at the UK approval.